Youhong P. Jiang
155 Nanjing North Street
Heping, 110001, China
Heping, 110001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
GPC3 Promotes Lung Squamous Cell Carcinoma Progression and HLA-A2-Restricted GPC3 Antigenic Peptide-Modified Dendritic Cell-Induced Cytotoxic T Lymphocytes to Kill Lung Squamous Cell Carcinoma Cells.
Journal: Journal of immunology research
Published: May 26, 2023
Dicoumarin with dimethyl thiocarbamate in the fluorescent detecting for Au3+ in water and cells.
Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Published: August 08, 2022
Construction and Evaluation of a Preoperative Prediction Model for Lymph Node Metastasis of cIA Lung Adenocarcinoma Using Random Forest.
Journal: Journal of oncology
Published: June 01, 2022
Correction to: GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma.
Journal: BMC pulmonary medicine
Published: November 23, 2021
Novel fluorescent probe based on dicoumarin for rapid on-site detection of Hg2+ in loess.
Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Published: December 01, 2020
GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma.
Journal: BMC pulmonary medicine
Published: November 22, 2020
Higher CD1a Levels Correlate with PD-L1 Expression and Predict Worse Overall Survival in Triple-Negative Breast Carcinoma.
Journal: Breast care (Basel, Switzerland)
Published: April 23, 2020
Long-term Outcomes of Endoscopic Resection for Gastric Subepithelial Tumors.
Journal: Surgical laparoscopy, endoscopy & percutaneous techniques
Published: January 14, 2020
Oleandrin induces apoptosis via activating endoplasmic reticulum stress in breast cancer cells.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 25, 2019
Mapping research trends of retinal vein occlusion from 2009 to 2018: a bibliometric analysis.
Journal: PeerJ
Published: March 16, 2019
miR-1 inhibits the proliferation of breast cancer stem cells by targeting EVI-1.
Journal: OncoTargets and therapy
Published: December 26, 2018
Last Updated: 09/26/2026